Issue 90, 2019

A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy

Abstract

A cyanine-derivative photosensitizer, CYBF2, was synthesized for photodynamic therapy of cancer. The photosensitizer can be activated by red-light with enhanced photostability compared to traditional cyanine photosensitizers. CYBF2 was able to generate singlet oxygen inside the cell mitochondria, which efficiently resulted in apoptosis of cancer cells.

Graphical abstract: A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
08 Aug 2019
Accepted
11 Oct 2019
First published
24 Oct 2019

Chem. Commun., 2019,55, 13542-13545

A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy

X. Zhao, Y. Yang, Y. Yu, S. Guo, W. Wang and S. Zhu, Chem. Commun., 2019, 55, 13542 DOI: 10.1039/C9CC06157F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements